Cambodia

Reimbursed Care Access

Cambodia maintains a prohibitive national drug-control framework and active law-enforcement approach to novel/illicit psychoactive substances while preserving medical use of essential anaesthetics (including ketamine) within its health system. Public financing is focused on essential, primary and inpatient services through schemes like the Health Equity Fund; there is no established reimbursed medical program for commercial psychedelic therapeutics (e.g., esketamine/Spravato) and most classic psychedelics are treated as controlled/illicit with access limited to sanctioned research or subject to criminal enforcement.